Primary Care, Self Monitoring Blood Glucose, Telemedicine, Type 2 Diabetes
Conditions
Brief summary
The purpose of this study is to evaluate the impact of a a real time teleassistance system in the clinical evolution of type 2 diabetic patients on self monitoring blood glucose in the Public National Primary Care System.
Detailed description
The UKPDS study in type 2 diabetes and the DCCT in type 1, showed that intensive blood glucose control and the following HBA1c decrease were associated with a decrease of diabetic complications. Introducing telecontrol elements in the real time follow up of the patients, should help to know continuously patient blood glucose profile and add if necessary immediately therapeutical variations, to maintain HbA1c levels as low as possible. The study compares type 2 diabetes patients performing self monitoring of blood glucose, followed up by their family doctor in their primary care unit with the extra support of a real time teleassistance system with type 2 diabetes patients performing self monitoring of blood glucose, followed up by their family doctor in their primary care unit.
Interventions
DEVICETelemedicine system
Possibility of sending the SMBG values of the patients to a web page via phone mobile sms messages. The HCP had a password access to this web page to check the blood glucose values of the patients and if necessary send to them sms messages with recommendations.
Sponsors
Roche Diabetes Care
Province of Malaga Health Department
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of type 2 Diabetes * on SMBG al least 6 months before * age superior of 30 years * controlled in province of Málaga Primary Care Units
Exclusion criteria
* having diabetic complications or other diseases that could make difficult to use the telemedicine system * patients who need a carer * not passing the initial training (low cultural level) * living in an area without mobile phone coverage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HBA1c Glycosylated hemoglobin | one year for every patient |
Secondary
| Measure | Time frame |
|---|---|
| Blood glucose, Total Cholesterol, HDL Cholesterol,LDL Cholesterol, Triglycerides, BMI, systolic and diastolic blood pressure and system adherence | one year for every patient |
Countries
Spain
Outcome results
None listed